Description
Inotiv, Inc. is a publicly USA traded contract research organization (CRO) that provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries.As a leading contract research organization (CRO), Inotiv supports discovery and nonclinical development through investigational new drug (IND) and beyond.The company works with all leading drug manufacturers and scientific institutions around the world. The development and testing of drugs takes several years. These studies cost millions of dollars. The results of the research are a trade secret that must be strictly protected. Inotiv, Inc. failed to accomplish this task. A large amount of research data from the last 10 years has become publicly available. The published data contains a complete report on the development and testing of dozens of drugs. The publication of this archive threatens the company with contract terminations and fines exceeding several hundred million dollars, which would lead to a total damage to the company's business reputation.